AU9751798A - Aminomethyl-benzo{a}quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases - Google Patents

Aminomethyl-benzo{a}quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases Download PDF

Info

Publication number
AU9751798A
AU9751798A AU97517/98A AU9751798A AU9751798A AU 9751798 A AU9751798 A AU 9751798A AU 97517/98 A AU97517/98 A AU 97517/98A AU 9751798 A AU9751798 A AU 9751798A AU 9751798 A AU9751798 A AU 9751798A
Authority
AU
Australia
Prior art keywords
benzo
hexahydro
methyl
methoxy
quinolizinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU97517/98A
Other languages
English (en)
Inventor
Thierry Imbert
Marc Marien
Patrice Mayer
Jean-Louis Vidaluc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU9751798A publication Critical patent/AU9751798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU97517/98A 1997-10-28 1998-10-26 Aminomethyl-benzo{a}quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases Abandoned AU9751798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9713499 1997-10-28
FR9713499A FR2770215B1 (fr) 1997-10-28 1997-10-28 Derives d'aminomethyl-benzo[a]quinolizidine, leur preparation et leur application en therapeutique pour les maladies neurodegeneratives
PCT/FR1998/002281 WO1999021856A1 (fr) 1997-10-28 1998-10-26 Derives d'aminomethyl-benzo[a]quinolizidine, leur preparation et leur application en therapeutique pour les maladies neurodegeneratives

Publications (1)

Publication Number Publication Date
AU9751798A true AU9751798A (en) 1999-05-17

Family

ID=9512729

Family Applications (1)

Application Number Title Priority Date Filing Date
AU97517/98A Abandoned AU9751798A (en) 1997-10-28 1998-10-26 Aminomethyl-benzo{a}quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases

Country Status (8)

Country Link
EP (1) EP1027350A1 (ja)
JP (1) JP2001521034A (ja)
CN (1) CN1278260A (ja)
AU (1) AU9751798A (ja)
BR (1) BR9813303A (ja)
CA (1) CA2307748A1 (ja)
FR (1) FR2770215B1 (ja)
WO (1) WO1999021856A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016454D0 (en) 2000-07-04 2000-08-23 Hoffmann La Roche Thienopyrrolidinones
US8084492B2 (en) 2004-11-19 2011-12-27 The New Industry Research Organization Benzofuran compound and pharmaceutical composition containing the same
ES2525932T3 (es) * 2006-05-02 2015-01-02 The Trustees Of The University Of Pennsylvania Derivados de dihidrotetrabenazina radiomarcados y su uso como agentes de imagenología
GB2463451A (en) * 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
FR2976287B1 (fr) * 2011-06-09 2013-07-05 Pf Medicament Derives benzoquinolizidines, leur procede de preparation et leurs applications en therapeutique
US9115149B2 (en) * 2011-09-19 2015-08-25 Vitas Pharma Research Private Limited Heterocyclic compounds as inhibitors of fatty acid biosysnthesis for bacterial infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8416432D0 (en) * 1984-06-28 1984-08-01 Wyeth John & Brother Ltd Benzoquinolizines

Also Published As

Publication number Publication date
CA2307748A1 (fr) 1999-05-06
FR2770215A1 (fr) 1999-04-30
JP2001521034A (ja) 2001-11-06
WO1999021856A1 (fr) 1999-05-06
BR9813303A (pt) 2000-08-29
FR2770215B1 (fr) 2000-01-14
EP1027350A1 (fr) 2000-08-16
CN1278260A (zh) 2000-12-27

Similar Documents

Publication Publication Date Title
JP6717457B2 (ja) Ｗｅｅ１阻害剤としての１，２−ジヒドロ−３Ｈ−ピラゾロ［３，４−ｄ］ピリミジン−３−オン誘導体
US5338849A (en) Azaindoles, preparation processes and medicinal products containing them
US5708018A (en) 2-aminoindans as selective dopamine D3 ligands
CZ20003355A3 (cs) Bicyklo[2,2,1]heptany a příbuzné sloučeniny, farmaceutické kompozice a způsoby léčení na jejich bázi
BR112021015853A2 (pt) Compostos de tieno[3,2-b]piridin-7-amina para o tratamento de disautonomia familiar
CA1200241A (en) Pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydro- benzo¬g|quinoline derivatives
WO2018034702A1 (en) Beta-amino-isoquinolinyl amide compounds
AU682768B2 (en) Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
CA1268764A (fr) Derives du dihydro-2,3 benzofuranne, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
KR20000005388A (ko) 아미노이소퀴놀린 및 아미노티에노피리딘 유도체 및 소염제로서의 그의 용도
KR20220127839A (ko) Khk 억제 효과를 갖는 화합물
IE65619B1 (en) Use of gamma amino butyric acid autoreceptor antagonists for the manufacture of medicaments
AU9751798A (en) Aminomethyl-benzo{a}quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases
DE69418321T2 (de) Tricyclische benzodiazepine, ihr verwendung und herstellung
CA2211299A1 (en) Bicyclic isothiourea derivatives useful in therapy
FI89492B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla tetrahydro-6H-tiazolo/5,4-d/azepiner
AU706755B2 (en) Benzisothiazolyl-substituted aminomethylchromans
SK2022003A3 (en) Novel compounds and their use as glycine transport inhibitors
US6825213B2 (en) β3-adrenoreceptor agonists, agonist compositions and methods of using
GB1598667A (en) 1,3-dioxolane derivatives and their use in the preparation of 1-amino-3-aryloxy-2-propanols
US5719145A (en) Amidine derivatives and platelet aggregation inhibitor containing the same
SU1731044A3 (ru) Способ получени тризамещенных аминов или их фармакологически-приемлемых солей в виде рацемата или оптически активных изомеров
JP4871273B2 (ja) ４−トリフルオロメトキシフェノキシベンゾール−４’−スルホン酸、その製造法および薬剤としての使用
CN106065012A (zh) 咪唑类化合物
JP2010508334A (ja) アミノベンゾシクロヘプテン誘導体、その調製方法及び治療におけるその使用

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted